| |
Endoscopic BE
| |
|---|
| |
Negative (n = 94)
|
Positive (n = 69)
|
P-value
|
|---|
|
Patients profiles
| | | |
|
Age
| | | |
|
median; range (years)
|
60; 23–80
|
60; 30–77
|
0.8825*
|
|
Sex
| | | |
|
Female (%)
|
48 (51.1)
|
32 (46.4)
|
0.5542**
|
|
BMI
| | | |
|
median; range
|
24.1; 19.2–39.7
|
25.8; 19.2–43.6
|
0.1354*
|
|
Endoscopic results
| | | |
|
Hiatal hernia (%)
|
11 (11.7)
|
30 (43.5)
|
<0.0001**
|
|
Erosive esophagitis (%)
|
13 (13.8)
|
21 (30.4)
|
0.0099**
|
|
Abdominal surface area
| | | |
|
VAT (cm2)
|
97.45 (19.9–514.2)
|
120.2 (27.6–398.8)
|
0.0089*
|
|
SAT (cm2)
|
158.15 (34.5–428.7)
|
180.4 (35.2–484.8)
|
0.3169*
|
|
Circulating factors secreted from adipocytes
| | | |
|
Leptin (ng/mL)
|
9.45 (2.5–27.6)
|
12.15 (2.7–26.4)
|
0.5058*
|
|
Adiponectin (μg/mL)
|
7.9 (3.2–21.4)
|
5.6 (3.2–12.5)
|
0.0089*
|
|
Other laboratory parameters
| | | |
|
AST (U/L)
|
24 (12–112)
|
27 (12–204)
|
0.0789*
|
|
ALT (U/L)
|
30 (4–198)
|
32 (11–258)
|
0.0645*
|
|
CHE (U/L)
|
341 (208–719)
|
372 (198–545)
|
0.0225*
|
|
HDL (mg/dL)
|
57 (23–106)
|
50 (28–93)
|
0.1158*
|
|
LDL (mg/dL)
|
125.5 (40–202)
|
125 (61–241)
|
0.7548*
|
|
TG (mg/dL)
|
120 (50–524)
|
145 (52–809)
|
0.1076*
|
|
HOMA-R
|
2.444 (0.578–26.929)
|
3.184 (1.102–13.743)
|
0.3538*
|
- *Mann-Whitney U test, **Chi square test.
